Literature DB >> 23245233

LC-MS/MS determination of nevadensin in rat plasma and its application in pharmacokinetic studies.

Hongju Liu1, Chong Yan, Chunmin Li, Li Lin.   

Abstract

A simple, sensitive and specific liquid chromatography-electrospray tandem mass spectrometry (LC-MS/MS) method was developed and validated to quantitate nevadensin in rat plasma using genistein as the internal standard (IS). The assay was based on protein precipitation treatment with acetonitrile and liquid chromatography performed on a reverse-phase Zorbax SB-C(18) column (50 mm × 2.1 mm, 1.8 μm). Elution was achieved with a mobile phase consisted of aqueous solution containing 0.1% formic acid (solvent A) and methanol solution containing 0.1% formic acid (solvent B) at a flow rate of 300 μL/min (30:70, v/v). Quantification was through tandem-mass spectrometry with positive electrospray ionization (ESI) and multiple reaction monitoring (MRM) at m/z 345.1→315.1 and 271.1→215.1 for nevadensin and IS, respectively. Calibration curves were linear over the nevadensin rat plasma concentration range of 0.1-300 ng/mL. The lower limit of quantification (LLOQ) was 0.100 ng/mL and the inter- and intra-day accuracy and precision ranged between -1.67% and 7.60%. The average recovery of nevadensin was 95.6-99.1%. The validated method was successfully applied to the pharmacokinetic evaluation of nevadensin using the rat as an animal model following an oral administration of 50mg/kg nevadensin.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23245233     DOI: 10.1016/j.jpba.2012.10.021

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Topoisomerase poisoning by the flavonoid nevadensin triggers DNA damage and apoptosis in human colon carcinoma HT29 cells.

Authors:  Lena Müller; Larissa Rhonda Friederike Schütte; David Bücksteeg; Julian Alfke; Thomas Uebel; Melanie Esselen
Journal:  Arch Toxicol       Date:  2021-10-12       Impact factor: 5.153

2.  In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes.

Authors:  Yang Li; Jing Qin; Hong Wu; Yongmei Xu; Li Zhang; Keren Su; Ying Cui; Haiping Wang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.